Charcoal

N/A

Report date: 2026/03/20 20:03:07

Base Information

Drug NameCharcoal
Drug Alias NameKremezinZysaKremezin Fine GranulesAST-120MP-146
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsKidney Failure, ChronicRenal Insufficiency, ChronicAsthma +[9] 
Global Approved IndicationsKidney Failure, Chronic
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1991/10/04
Country/TerritoryCzechiaBelgiumCanada +[22] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesKureha Co
China Registration ClassN/A

Develop Information

Active CompaniesMitsubishi Tanabe Pharma
Inactive CompaniesMitsubishi Tanabe Pharma CorpOcera Therapeutics IncOrion Corporation Orion Pharma
Active IndicationsKidney Failure, Chronic
Inactive IndicationsRenal Insufficiency, ChronicAsthmaHepatic Encephalopathy +[8] 

Other Information

ATC CodeA07BA01
Related LinksN/A